Search results
Medicines. Gilead is committed to helping improve the lives of people around the world by bringing forward medicines that prevent, treat and cure devastating diseases. We currently offer more than 25 therapies in the United States and are rapidly growing our portfolio through internal research and development, as well as collaborations with ...
Gilead is committed to advancing care for people around the world by bringing forward medicines to address unmet medical needs in virology, oncology and inflammation. We do this through internal research and development, as well as through collaborations with academic and industry partners. Since 1987, Gilead has commercialized more than 25 ...
Apr 25, 2024 · Phase 1. Inflammatory Diseases. Cilofexor / firsocostat / semaglutide combination. Nonalcoholic steatohepatitis. Phase 2. Inflammatory diseases. Learn about the investigational medicines in Gilead's pipeline with the potential to help advance care in COVID-19, HIV, viral hepatitis, cancer and inflammation.
Gilead Sciences to Release Fourth Quarter & Full Year 2023 Financial Results on Tuesday, February 6, 2024. January 22, 2024. Gilead Provides Update on Phase 3 EVOKE-01 Study. Read the latest news about Gilead's work in COVID-19, HIV, viral hepatitis, cancer and other areas.
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS ...
Jun 20, 2024 · Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer.
Gilead Sciences | 628,253 followers on LinkedIn. Creating Possible | At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and ...
